Analysis of vitamin D levels in patients with and without statin-associated myalgia - a systematic review and meta-analysis of 7 studies with 2420 patients.
Identifieur interne : 003026 ( PubMed/Curation ); précédent : 003025; suivant : 003027Analysis of vitamin D levels in patients with and without statin-associated myalgia - a systematic review and meta-analysis of 7 studies with 2420 patients.
Auteurs : Marta Michalska-Kasiczak [Pologne] ; Amirhossein Sahebkar [Australie] ; Dimitri P. Mikhailidis [Royaume-Uni] ; Jacek Rysz [Pologne] ; Paul Muntner [États-Unis] ; Peter P. Toth [États-Unis] ; Steven R. Jones [États-Unis] ; Manfredi Rizzo [Italie] ; G. Kees Hovingh [Pays-Bas] ; Michel Farnier [France] ; Patrick M. Moriarty [États-Unis] ; Vera A. Bittner [États-Unis] ; Gregory Y H. Lip [Royaume-Uni] ; Maciej Banach [Pologne]Source :
- International journal of cardiology [ 1874-1754 ] ; 2015.
Descripteurs français
- KwdFr :
- MESH :
- diagnostic : Myalgie.
- effets indésirables : Inhibiteurs de l'hydroxyméthylglutaryl-CoA réductase.
- sang : Marqueurs biologiques, Myalgie, Vitamine D.
- Humains, Myalgie, Étude d'observation comme sujet.
English descriptors
- KwdEn :
- MESH :
- chemical , adverse effects : Hydroxymethylglutaryl-CoA Reductase Inhibitors.
- chemical , blood : Biomarkers, Vitamin D.
- blood : Myalgia.
- chemically induced : Myalgia.
- diagnosis : Myalgia.
- methods : Observational Studies as Topic.
- Humans.
Abstract
Vitamin D (vit D) deficiency may be associated with an increased risk of statin-related symptomatic myalgia in statin-treated patients. The aim of this meta-analysis was to substantiate the role of serum vitamin D levels in statin-associated myalgia.
DOI: 10.1016/j.ijcard.2014.10.118
PubMed: 25464233
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :003122
Links to Exploration step
pubmed:25464233Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Analysis of vitamin D levels in patients with and without statin-associated myalgia - a systematic review and meta-analysis of 7 studies with 2420 patients.</title>
<author><name sortKey="Michalska Kasiczak, Marta" sort="Michalska Kasiczak, Marta" uniqKey="Michalska Kasiczak M" first="Marta" last="Michalska-Kasiczak">Marta Michalska-Kasiczak</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Hypertension, Chair of Nephrology and Hypertension, Medical University of Lodz, Poland.</nlm:affiliation>
<country xml:lang="fr">Pologne</country>
<wicri:regionArea>Department of Hypertension, Chair of Nephrology and Hypertension, Medical University of Lodz</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Sahebkar, Amirhossein" sort="Sahebkar, Amirhossein" uniqKey="Sahebkar A" first="Amirhossein" last="Sahebkar">Amirhossein Sahebkar</name>
<affiliation wicri:level="1"><nlm:affiliation>Biotechnology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran; Metabolic Research Centre, Royal Perth Hospital, School of Medicine and Pharmacology, University of Western Australia, Perth, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Biotechnology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran; Metabolic Research Centre, Royal Perth Hospital, School of Medicine and Pharmacology, University of Western Australia, Perth</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Mikhailidis, Dimitri P" sort="Mikhailidis, Dimitri P" uniqKey="Mikhailidis D" first="Dimitri P" last="Mikhailidis">Dimitri P. Mikhailidis</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Clinical Biochemistry, Royal Free Campus, University College London Medical School, University College London (UCL), London, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Department of Clinical Biochemistry, Royal Free Campus, University College London Medical School, University College London (UCL), London</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Rysz, Jacek" sort="Rysz, Jacek" uniqKey="Rysz J" first="Jacek" last="Rysz">Jacek Rysz</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Nephrology, Hypertension and Family Medicine, Chair of Nephrology and Hypertension, Medical University of Lodz, Poland.</nlm:affiliation>
<country xml:lang="fr">Pologne</country>
<wicri:regionArea>Department of Nephrology, Hypertension and Family Medicine, Chair of Nephrology and Hypertension, Medical University of Lodz</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Muntner, Paul" sort="Muntner, Paul" uniqKey="Muntner P" first="Paul" last="Muntner">Paul Muntner</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Toth, Peter P" sort="Toth, Peter P" uniqKey="Toth P" first="Peter P" last="Toth">Peter P. Toth</name>
<affiliation wicri:level="1"><nlm:affiliation>Preventive Cardiology, CGH Medical Center, Sterling, IL, USA; The Johns Hopkins Ciccarone Center for the Prevention of Heart Disease, Baltimore, MD, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Preventive Cardiology, CGH Medical Center, Sterling, IL, USA; The Johns Hopkins Ciccarone Center for the Prevention of Heart Disease, Baltimore, MD</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Jones, Steven R" sort="Jones, Steven R" uniqKey="Jones S" first="Steven R" last="Jones">Steven R. Jones</name>
<affiliation wicri:level="1"><nlm:affiliation>The Johns Hopkins Ciccarone Center for the Prevention of Heart Disease, Baltimore, MD, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>The Johns Hopkins Ciccarone Center for the Prevention of Heart Disease, Baltimore, MD</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Rizzo, Manfredi" sort="Rizzo, Manfredi" uniqKey="Rizzo M" first="Manfredi" last="Rizzo">Manfredi Rizzo</name>
<affiliation wicri:level="1"><nlm:affiliation>Biomedical Department of Internal Medicine and Medical Specialties, University of Palermo, Italy.</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Biomedical Department of Internal Medicine and Medical Specialties, University of Palermo</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Kees Hovingh, G" sort="Kees Hovingh, G" uniqKey="Kees Hovingh G" first="G" last="Kees Hovingh">G. Kees Hovingh</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Vascular Medicine, Academic Medical Center, Amsterdam, Netherlands.</nlm:affiliation>
<country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>Department of Vascular Medicine, Academic Medical Center, Amsterdam</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Farnier, Michel" sort="Farnier, Michel" uniqKey="Farnier M" first="Michel" last="Farnier">Michel Farnier</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Lipidology, Point Medical, Dijon, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Department of Lipidology, Point Medical, Dijon</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Moriarty, Patrick M" sort="Moriarty, Patrick M" uniqKey="Moriarty P" first="Patrick M" last="Moriarty">Patrick M. Moriarty</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Medicine, Schools of Pharmacy and Medicine, The University of Kansas Medical Center, KS City, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Medicine, Schools of Pharmacy and Medicine, The University of Kansas Medical Center, KS City</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Bittner, Vera A" sort="Bittner, Vera A" uniqKey="Bittner V" first="Vera A" last="Bittner">Vera A. Bittner</name>
<affiliation wicri:level="1"><nlm:affiliation>Division of Cardiovascular Disease, Preventive Cardiology Section, University of Alabama at Birmingham, Birmingham, AL, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Division of Cardiovascular Disease, Preventive Cardiology Section, University of Alabama at Birmingham, Birmingham, AL</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Lip, Gregory Y H" sort="Lip, Gregory Y H" uniqKey="Lip G" first="Gregory Y H" last="Lip">Gregory Y H. Lip</name>
<affiliation wicri:level="1"><nlm:affiliation>University of Birmingham Centre for Cardiovascular Sciences, City Hospital, Birmingham, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>University of Birmingham Centre for Cardiovascular Sciences, City Hospital, Birmingham</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Banach, Maciej" sort="Banach, Maciej" uniqKey="Banach M" first="Maciej" last="Banach">Maciej Banach</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Hypertension, Chair of Nephrology and Hypertension, Medical University of Lodz, Poland. Electronic address: maciejbanach@aol.co.uk.</nlm:affiliation>
<country xml:lang="fr">Pologne</country>
<wicri:regionArea>Department of Hypertension, Chair of Nephrology and Hypertension, Medical University of Lodz</wicri:regionArea>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2015">2015</date>
<idno type="RBID">pubmed:25464233</idno>
<idno type="pmid">25464233</idno>
<idno type="doi">10.1016/j.ijcard.2014.10.118</idno>
<idno type="wicri:Area/PubMed/Corpus">003122</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">003122</idno>
<idno type="wicri:Area/PubMed/Curation">003026</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">003026</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Analysis of vitamin D levels in patients with and without statin-associated myalgia - a systematic review and meta-analysis of 7 studies with 2420 patients.</title>
<author><name sortKey="Michalska Kasiczak, Marta" sort="Michalska Kasiczak, Marta" uniqKey="Michalska Kasiczak M" first="Marta" last="Michalska-Kasiczak">Marta Michalska-Kasiczak</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Hypertension, Chair of Nephrology and Hypertension, Medical University of Lodz, Poland.</nlm:affiliation>
<country xml:lang="fr">Pologne</country>
<wicri:regionArea>Department of Hypertension, Chair of Nephrology and Hypertension, Medical University of Lodz</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Sahebkar, Amirhossein" sort="Sahebkar, Amirhossein" uniqKey="Sahebkar A" first="Amirhossein" last="Sahebkar">Amirhossein Sahebkar</name>
<affiliation wicri:level="1"><nlm:affiliation>Biotechnology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran; Metabolic Research Centre, Royal Perth Hospital, School of Medicine and Pharmacology, University of Western Australia, Perth, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Biotechnology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran; Metabolic Research Centre, Royal Perth Hospital, School of Medicine and Pharmacology, University of Western Australia, Perth</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Mikhailidis, Dimitri P" sort="Mikhailidis, Dimitri P" uniqKey="Mikhailidis D" first="Dimitri P" last="Mikhailidis">Dimitri P. Mikhailidis</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Clinical Biochemistry, Royal Free Campus, University College London Medical School, University College London (UCL), London, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Department of Clinical Biochemistry, Royal Free Campus, University College London Medical School, University College London (UCL), London</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Rysz, Jacek" sort="Rysz, Jacek" uniqKey="Rysz J" first="Jacek" last="Rysz">Jacek Rysz</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Nephrology, Hypertension and Family Medicine, Chair of Nephrology and Hypertension, Medical University of Lodz, Poland.</nlm:affiliation>
<country xml:lang="fr">Pologne</country>
<wicri:regionArea>Department of Nephrology, Hypertension and Family Medicine, Chair of Nephrology and Hypertension, Medical University of Lodz</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Muntner, Paul" sort="Muntner, Paul" uniqKey="Muntner P" first="Paul" last="Muntner">Paul Muntner</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Toth, Peter P" sort="Toth, Peter P" uniqKey="Toth P" first="Peter P" last="Toth">Peter P. Toth</name>
<affiliation wicri:level="1"><nlm:affiliation>Preventive Cardiology, CGH Medical Center, Sterling, IL, USA; The Johns Hopkins Ciccarone Center for the Prevention of Heart Disease, Baltimore, MD, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Preventive Cardiology, CGH Medical Center, Sterling, IL, USA; The Johns Hopkins Ciccarone Center for the Prevention of Heart Disease, Baltimore, MD</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Jones, Steven R" sort="Jones, Steven R" uniqKey="Jones S" first="Steven R" last="Jones">Steven R. Jones</name>
<affiliation wicri:level="1"><nlm:affiliation>The Johns Hopkins Ciccarone Center for the Prevention of Heart Disease, Baltimore, MD, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>The Johns Hopkins Ciccarone Center for the Prevention of Heart Disease, Baltimore, MD</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Rizzo, Manfredi" sort="Rizzo, Manfredi" uniqKey="Rizzo M" first="Manfredi" last="Rizzo">Manfredi Rizzo</name>
<affiliation wicri:level="1"><nlm:affiliation>Biomedical Department of Internal Medicine and Medical Specialties, University of Palermo, Italy.</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Biomedical Department of Internal Medicine and Medical Specialties, University of Palermo</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Kees Hovingh, G" sort="Kees Hovingh, G" uniqKey="Kees Hovingh G" first="G" last="Kees Hovingh">G. Kees Hovingh</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Vascular Medicine, Academic Medical Center, Amsterdam, Netherlands.</nlm:affiliation>
<country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>Department of Vascular Medicine, Academic Medical Center, Amsterdam</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Farnier, Michel" sort="Farnier, Michel" uniqKey="Farnier M" first="Michel" last="Farnier">Michel Farnier</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Lipidology, Point Medical, Dijon, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Department of Lipidology, Point Medical, Dijon</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Moriarty, Patrick M" sort="Moriarty, Patrick M" uniqKey="Moriarty P" first="Patrick M" last="Moriarty">Patrick M. Moriarty</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Medicine, Schools of Pharmacy and Medicine, The University of Kansas Medical Center, KS City, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Medicine, Schools of Pharmacy and Medicine, The University of Kansas Medical Center, KS City</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Bittner, Vera A" sort="Bittner, Vera A" uniqKey="Bittner V" first="Vera A" last="Bittner">Vera A. Bittner</name>
<affiliation wicri:level="1"><nlm:affiliation>Division of Cardiovascular Disease, Preventive Cardiology Section, University of Alabama at Birmingham, Birmingham, AL, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Division of Cardiovascular Disease, Preventive Cardiology Section, University of Alabama at Birmingham, Birmingham, AL</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Lip, Gregory Y H" sort="Lip, Gregory Y H" uniqKey="Lip G" first="Gregory Y H" last="Lip">Gregory Y H. Lip</name>
<affiliation wicri:level="1"><nlm:affiliation>University of Birmingham Centre for Cardiovascular Sciences, City Hospital, Birmingham, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>University of Birmingham Centre for Cardiovascular Sciences, City Hospital, Birmingham</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Banach, Maciej" sort="Banach, Maciej" uniqKey="Banach M" first="Maciej" last="Banach">Maciej Banach</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Hypertension, Chair of Nephrology and Hypertension, Medical University of Lodz, Poland. Electronic address: maciejbanach@aol.co.uk.</nlm:affiliation>
<country xml:lang="fr">Pologne</country>
<wicri:regionArea>Department of Hypertension, Chair of Nephrology and Hypertension, Medical University of Lodz</wicri:regionArea>
</affiliation>
</author>
</analytic>
<series><title level="j">International journal of cardiology</title>
<idno type="eISSN">1874-1754</idno>
<imprint><date when="2015" type="published">2015</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Biomarkers (blood)</term>
<term>Humans</term>
<term>Hydroxymethylglutaryl-CoA Reductase Inhibitors (adverse effects)</term>
<term>Myalgia (blood)</term>
<term>Myalgia (chemically induced)</term>
<term>Myalgia (diagnosis)</term>
<term>Observational Studies as Topic (methods)</term>
<term>Vitamin D (blood)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Humains</term>
<term>Inhibiteurs de l'hydroxyméthylglutaryl-CoA réductase (effets indésirables)</term>
<term>Marqueurs biologiques (sang)</term>
<term>Myalgie ()</term>
<term>Myalgie (diagnostic)</term>
<term>Myalgie (sang)</term>
<term>Vitamine D (sang)</term>
<term>Étude d'observation comme sujet ()</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Hydroxymethylglutaryl-CoA Reductase Inhibitors</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="blood" xml:lang="en"><term>Biomarkers</term>
<term>Vitamin D</term>
</keywords>
<keywords scheme="MESH" qualifier="blood" xml:lang="en"><term>Myalgia</term>
</keywords>
<keywords scheme="MESH" qualifier="chemically induced" xml:lang="en"><term>Myalgia</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Myalgia</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr"><term>Myalgie</term>
</keywords>
<keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Inhibiteurs de l'hydroxyméthylglutaryl-CoA réductase</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Observational Studies as Topic</term>
</keywords>
<keywords scheme="MESH" qualifier="sang" xml:lang="fr"><term>Marqueurs biologiques</term>
<term>Myalgie</term>
<term>Vitamine D</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Humans</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Humains</term>
<term>Myalgie</term>
<term>Étude d'observation comme sujet</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Vitamin D (vit D) deficiency may be associated with an increased risk of statin-related symptomatic myalgia in statin-treated patients. The aim of this meta-analysis was to substantiate the role of serum vitamin D levels in statin-associated myalgia.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25464233</PMID>
<DateCreated><Year>2015</Year>
<Month>02</Month>
<Day>02</Day>
</DateCreated>
<DateCompleted><Year>2015</Year>
<Month>08</Month>
<Day>28</Day>
</DateCompleted>
<DateRevised><Year>2015</Year>
<Month>11</Month>
<Day>19</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1874-1754</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>178</Volume>
<PubDate><Year>2015</Year>
<Month>Jan</Month>
<Day>15</Day>
</PubDate>
</JournalIssue>
<Title>International journal of cardiology</Title>
<ISOAbbreviation>Int. J. Cardiol.</ISOAbbreviation>
</Journal>
<ArticleTitle>Analysis of vitamin D levels in patients with and without statin-associated myalgia - a systematic review and meta-analysis of 7 studies with 2420 patients.</ArticleTitle>
<Pagination><MedlinePgn>111-6</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ijcard.2014.10.118</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0167-5273(14)02055-5</ELocationID>
<Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Vitamin D (vit D) deficiency may be associated with an increased risk of statin-related symptomatic myalgia in statin-treated patients. The aim of this meta-analysis was to substantiate the role of serum vitamin D levels in statin-associated myalgia.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">The search included PUBMED, Cochrane Library, Scopus, and EMBASE from January 1, 1987 to April 1, 2014 to identify studies that investigated the impact of vit D levels in statin-treated subjects with and without myalgia. Two independent reviewers extracted data on study characteristics, methods and outcomes. Quantitative data synthesis was performed using a fixed-effect model.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">The electronic search yielded 437 articles; of those 20 were scrutinized as full texts and 13 studies were considered unsuitable. The final analysis included 7 studies with 2420 statin-treated patients divided into subgroups of patients with (n=666 [27.5%]) or without (n=1754) myalgia. Plasma vit D concentrations in the symptomatic and asymptomatic subgroups were 28.4±13.80ng/mL and 34.86±11.63ng/mL, respectively. The combination of data from individual observational studies showed that vit D plasma concentrations were significantly lower in patients with statin-associated myalgia compared with patients not manifesting this side effect (weighted mean difference -9.41ng/mL; 95% confidence interval: -10.17 to -8.64; p<0.00001).</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This meta-analysis provides evidence that low vit D levels are associated with myalgia in patients on statin therapy. Randomized controlled trials are necessary to establish whether vitamin D supplementation reduces the risk for statin-associated myalgia.</AbstractText>
<CopyrightInformation>Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Michalska-Kasiczak</LastName>
<ForeName>Marta</ForeName>
<Initials>M</Initials>
<AffiliationInfo><Affiliation>Department of Hypertension, Chair of Nephrology and Hypertension, Medical University of Lodz, Poland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Sahebkar</LastName>
<ForeName>Amirhossein</ForeName>
<Initials>A</Initials>
<AffiliationInfo><Affiliation>Biotechnology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran; Metabolic Research Centre, Royal Perth Hospital, School of Medicine and Pharmacology, University of Western Australia, Perth, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Mikhailidis</LastName>
<ForeName>Dimitri P</ForeName>
<Initials>DP</Initials>
<AffiliationInfo><Affiliation>Department of Clinical Biochemistry, Royal Free Campus, University College London Medical School, University College London (UCL), London, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Rysz</LastName>
<ForeName>Jacek</ForeName>
<Initials>J</Initials>
<AffiliationInfo><Affiliation>Department of Nephrology, Hypertension and Family Medicine, Chair of Nephrology and Hypertension, Medical University of Lodz, Poland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Muntner</LastName>
<ForeName>Paul</ForeName>
<Initials>P</Initials>
<AffiliationInfo><Affiliation>Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Toth</LastName>
<ForeName>Peter P</ForeName>
<Initials>PP</Initials>
<AffiliationInfo><Affiliation>Preventive Cardiology, CGH Medical Center, Sterling, IL, USA; The Johns Hopkins Ciccarone Center for the Prevention of Heart Disease, Baltimore, MD, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Jones</LastName>
<ForeName>Steven R</ForeName>
<Initials>SR</Initials>
<AffiliationInfo><Affiliation>The Johns Hopkins Ciccarone Center for the Prevention of Heart Disease, Baltimore, MD, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Rizzo</LastName>
<ForeName>Manfredi</ForeName>
<Initials>M</Initials>
<AffiliationInfo><Affiliation>Biomedical Department of Internal Medicine and Medical Specialties, University of Palermo, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Kees Hovingh</LastName>
<ForeName>G</ForeName>
<Initials>G</Initials>
<AffiliationInfo><Affiliation>Department of Vascular Medicine, Academic Medical Center, Amsterdam, Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Farnier</LastName>
<ForeName>Michel</ForeName>
<Initials>M</Initials>
<AffiliationInfo><Affiliation>Department of Lipidology, Point Medical, Dijon, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Moriarty</LastName>
<ForeName>Patrick M</ForeName>
<Initials>PM</Initials>
<AffiliationInfo><Affiliation>Department of Medicine, Schools of Pharmacy and Medicine, The University of Kansas Medical Center, KS City, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Bittner</LastName>
<ForeName>Vera A</ForeName>
<Initials>VA</Initials>
<AffiliationInfo><Affiliation>Division of Cardiovascular Disease, Preventive Cardiology Section, University of Alabama at Birmingham, Birmingham, AL, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Lip</LastName>
<ForeName>Gregory Y H</ForeName>
<Initials>GY</Initials>
<AffiliationInfo><Affiliation>University of Birmingham Centre for Cardiovascular Sciences, City Hospital, Birmingham, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Banach</LastName>
<ForeName>Maciej</ForeName>
<Initials>M</Initials>
<AffiliationInfo><Affiliation>Department of Hypertension, Chair of Nephrology and Hypertension, Medical University of Lodz, Poland. Electronic address: maciejbanach@aol.co.uk.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><CollectiveName>Lipid and Blood Pressure Meta-analysis Collaboration (LBPMC) Group</CollectiveName>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D017418">Meta-Analysis</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2014</Year>
<Month>10</Month>
<Day>22</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>Netherlands</Country>
<MedlineTA>Int J Cardiol</MedlineTA>
<NlmUniqueID>8200291</NlmUniqueID>
<ISSNLinking>0167-5273</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D019161">Hydroxymethylglutaryl-CoA Reductase Inhibitors</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>1406-16-2</RegistryNumber>
<NameOfSubstance UI="D014807">Vitamin D</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName>
<QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D019161" MajorTopicYN="N">Hydroxymethylglutaryl-CoA Reductase Inhibitors</DescriptorName>
<QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D063806" MajorTopicYN="N">Myalgia</DescriptorName>
<QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName>
<QualifierName UI="Q000139" MajorTopicYN="Y">chemically induced</QualifierName>
<QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D064887" MajorTopicYN="N">Observational Studies as Topic</DescriptorName>
<QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014807" MajorTopicYN="N">Vitamin D</DescriptorName>
<QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Myalgia</Keyword>
<Keyword MajorTopicYN="N">Statin intolerance</Keyword>
<Keyword MajorTopicYN="N">Statin-associated myalgia</Keyword>
<Keyword MajorTopicYN="N">Vitamin D</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year>
<Month>09</Month>
<Day>11</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2014</Year>
<Month>10</Month>
<Day>21</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2014</Year>
<Month>12</Month>
<Day>3</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2014</Year>
<Month>12</Month>
<Day>3</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2015</Year>
<Month>9</Month>
<Day>1</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">25464233</ArticleId>
<ArticleId IdType="pii">S0167-5273(14)02055-5</ArticleId>
<ArticleId IdType="doi">10.1016/j.ijcard.2014.10.118</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003026 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 003026 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Asie |area= AustralieFrV1 |flux= PubMed |étape= Curation |type= RBID |clé= pubmed:25464233 |texte= Analysis of vitamin D levels in patients with and without statin-associated myalgia - a systematic review and meta-analysis of 7 studies with 2420 patients. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i -Sk "pubmed:25464233" \ | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd \ | NlmPubMed2Wicri -a AustralieFrV1
![]() | This area was generated with Dilib version V0.6.33. | ![]() |